Cargando…
Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis – a case series
BACKGROUND: The majority of patients with autoimmune hepatitis (AIH) achieve complete remission with established treatment regiments. In patients with intolerance or insufficient response to these drugs, the remaining options are limited and novel treatment approaches necessary. In primary biliary c...
Autores principales: | Kolev, Mirjam, Sarbu, Adela-Cristina, Möller, Burkhard, Maurer, Britta, Kollert, Florian, Semmo, Nasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883290/ https://www.ncbi.nlm.nih.gov/pubmed/36718275 http://dx.doi.org/10.1016/j.jtauto.2023.100189 |
Ejemplares similares
-
Rational development and application of biomarkers in the field of autoimmunity: A conceptual framework guiding clinicians and researchers
por: Kolev, Mirjam, et al.
Publicado: (2022) -
Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis
por: Kolev, Mirjam, et al.
Publicado: (2022) -
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021) -
A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2019) -
Primary Biliary Cholangitis Overlap With Autoimmune Hepatitis? A Case Report
por: Costa, Vitor, et al.
Publicado: (2021)